Global Hemodialysis and Peritoneal Dialysis Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Type;

Hemodialysis - [Conventional Hemodialysis, Short Daily Hemodialysis, and Nocturnal Hemodialysis], Peritoneal Dialysis - [Continuous Ambulatory Peritoneal Dialysis (CAPD), and Automated Peritoneal Dialysis (APD)]

By Product;

Device - [Machine, Dialyzers, Water Treament System, and Others], Consumables - [Bloodline, Concentrates, Catheters, and Others], and Services

By Procedure;

Hemodialysis, and Peritoneal Dialysis

By End Use;

Home-Based and Hospital-Based

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn134674588 Published Date: May, 2025 Updated Date: June, 2025

Introduction

Global Hemodialysis and Peritoneal Dialysis Market (USD Million), 2021 - 2031

Hemodialysis and Peritoneal Dialysis Market was valued at USD 77,769.71 million in the year 2024. The size of this market is expected to increase to USD 110,602.39 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.2%.


Global Hemodialysis and Peritoneal Dialysis Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 5.2 %


Study Period2025 - 2031
Base Year2024
CAGR (%)5.2 %
Market Size (2024)USD 77,769.71 Million
Market Size (2031)USD 110,602.39 Million
Market ConcentrationMedium
Report Pages345
77,769.71
2024
110,602.39
2031

Major Players

  • Fresenius Medical Care
  • Baxter International, Inc.
  • B. Braun Avitum AG
  • NIPRO Medical Corporation
  • DaVita Healthcare Partners, Inc.
  • NxStage
  • Medtronic
  • Asahi Kasei Medical Co., Ltd.

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Hemodialysis and Peritoneal Dialysis Market

Fragmented - Highly competitive market without dominant players


The hemodialysis and peritoneal dialysis market is witnessing robust growth, driven by the increasing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD). With over 10% of the population affected by CKD, the need for reliable renal replacement therapies is substantial. Among these, hemodialysis accounts for nearly 70% of total procedures, highlighting its widespread use due to its proven effectiveness and reliability.

Technological Innovations in Dialysis Systems
Technological advancements are playing a critical role in shaping this market. Modern dialysis systems now feature real-time monitoring, automated fluid management, and intelligent sensors, significantly improving patient outcomes and operational efficiency. These innovations have enhanced the precision and comfort of dialysis, contributing to their adoption in over 60% of treatment centers.

Rising Preference for Home-Based Therapies
There is a growing shift toward home-based dialysis, including peritoneal dialysis, which offers greater flexibility and convenience for patients. Currently, peritoneal dialysis accounts for around 30% of the dialysis market, reflecting a strong trend toward patient-centered care. This transition is further supported by increased patient awareness and efforts by healthcare providers to reduce the strain on hospital resources.

Supportive Policies and Reimbursement Structures
Favorable government policies and reimbursement structures are significantly boosting market expansion. In many regions, dialysis treatments are included in national healthcare programs, improving accessibility for a broader patient base. This supportive framework has driven increased uptake, with reimbursement policies covering over 50% of treatment costs in some areas.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By Product
    3. Market Snapshot, By Procedure
    4. Market Snapshot, By End Use
    5. Market Snapshot, By Region
  4. Global Hemodialysis and Peritoneal Dialysis Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing preference for home-based dialysis
        2. Rising geriatric population needing dialysis care
        3. Growing awareness about renal health
      2. Restraints
        1. High cost of dialysis treatments
        2. Limited access to dialysis in low-income regions
        3. Risk of infection and complications
      3. Opportunities
        1. Development of portable and wearable dialysis devices
        2. Integration of telemedicine in dialysis care
        3. Personalized medicine approaches in renal care
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Hemodialysis and Peritoneal Dialysis Market, By Type, 2021 - 2031 (USD Million)
      1. Hemodialysis
        1. Conventional Hemodialysis
        2. Short Daily Hemodialysis
        3. Nocturnal Hemodialysis
      2. Peritoneal Dialysis
        1. Continuous Ambulatory Peritoneal Dialysis (CAPD)
        2. Automated Peritoneal Dialysis (APD)
    2. Global Hemodialysis and Peritoneal Dialysis Market, By Product, 2021 - 2031 (USD Million)
      1. Device
        1. Machine
        2. Dialyzers
        3. Water Treament System
        4. Others
      2. Consumables
        1. Bloodline
        2. Concentrates
        3. Catheters
        4. Others
      3. Services
    3. Global Hemodialysis and Peritoneal Dialysis Market, By Procedure, 2021 - 2031 (USD Million)
      1. Hemodialysis
      2. Peritoneal Dialysis
    4. Global Hemodialysis and Peritoneal Dialysis Market, By End Use, 2021 - 2031 (USD Million)
      1. Home-Based
      2. Hospital-Based
    5. Global Hemodialysis and Peritoneal Dialysis Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Fresenius Medical Care
      2. Baxter International, Inc.
      3. B. Braun Avitum AG
      4. NIPRO Medical Corporation
      5. DaVita Healthcare Partners, Inc.
      6. NxStage
      7. Medtronic
      8. Asahi Kasei Medical Co., Ltd.
  7. Analyst Views
  8. Future Outlook of the Market